Skip to content

Application of bupivacaine liposome quadrate lumbotomy block in laparoscopic total abdominal hysterectomy: a multicenter, prospective, randomized controlled study

Application of bupivacaine liposome quadrate lumbotomy block in laparoscopic total abdominal hysterectomy: a multicenter, prospective, randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080561
Enrollment
Unknown
Registered
2024-02-01
Start date
2024-07-10
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperation pain

Interventions

Bupivacaine liposome injection group:Ultrasound-guided quadrate block was performed with bupivacaine liposome injection
Ropivacaine hydrochloride group:Ultrasound-guided quadrate block was performed with ropivacaine hydrochloride

Sponsors

Linyi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: a) Age 40-65 years old b) BMI18 ~ 30kg/m2 c) ASA Grade I ~ III. d) Patients undergoing laparoscopic total abdominal hysterectomy e) Voluntarily sign informed consent

Exclusion criteria

Exclusion criteria: a) Patients with contraindications to regional block; b) People who are allergic to the drugs used in the study or who have absolute contraindications in their use; c) Severe cardiovascular and cerebrovascular, liver and kidney insufficiency or arrhythmia; d) Have a history of mental illness or long-term history of taking psychotropic drugs or chronic analgesic drugs; e) Severe visual and writing defects or speech communication disorders; f) Patients with malignant tumors; g) The patient refuses to participate or the investigator considers the patient unfit to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Analgesic effect in 0-72h after operation;

Secondary

MeasureTime frame
Remedial analgesia ;

Countries

China

Contacts

Public ContactXiming Li

Linyi People's Hospital

13515397176@163.com+86 135 1539 7176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026